New 'Tumor-Seeking' radiation drug enters major prostate cancer trial
NCT ID NCT04720157
Summary
This large, late-stage trial is testing if adding a new targeted radiation drug (177Lu-PSMA-617) to standard hormone therapy works better than standard therapy alone for men whose prostate cancer has recently spread. The drug is designed to seek out and deliver radiation directly to prostate cancer cells throughout the body. The main goal is to see if the combination helps patients live longer without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Specialists of North Florida
Jacksonville, Florida, 32256, United States
-
Carolina Urologic Research Center
Myrtle Beach, South Carolina, 29572, United States
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Corewell Health William Beaum Hosp
Royal Oak, Michigan, 48073-6769, United States
-
Dallas VA Medical Center
Dallas, Texas, 75216, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Duke Univ Medical Center
Durham, North Carolina, 27710, United States
-
Florida Cancer Affiliates
Panama City, Florida, 32405, United States
-
Georgetown University-Lombardi Cancer Center
Washington D.C., District of Columbia, 20007, United States
-
Hartford Hospital
Hartford, Connecticut, 06102, United States
-
Hines VA Hospital
Hines, Illinois, 60141, United States
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
Levine Cancer Institute
Charlotte, North Carolina, 28203, United States
-
MD Anderson
Houston, Texas, 77030, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mayo Clinic - Arizona Mayo Clinic Hospital
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic Arizona
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic Jacksonville
Jacksonville, Florida, 32224, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
-
Medical College Of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Memorial Sloan Kettering Cancer Ctr
New York, New York, 10065, United States
-
Miami Cancer Institute at Bapt
Miami, Florida, 33173, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
Nebraska Cancer Specialists
Omaha, Nebraska, 68130, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Novartis Investigative Site
Innsbruck, Tyrol, 6020, Austria
-
Novartis Investigative Site
Linz, 4020, Austria
-
Novartis Investigative Site
Vienna, 1090, Austria
-
Novartis Investigative Site
Brussels, 1200, Belgium
-
Novartis Investigative Site
Ghent, 9000, Belgium
-
Novartis Investigative Site
Vancouver, British Columbia, V5Z 1M9, Canada
-
Novartis Investigative Site
Hamilton, Ontario, L8V 5C2, Canada
-
Novartis Investigative Site
Toronto, Ontario, M4N 3M5, Canada
-
Novartis Investigative Site
Montreal, Quebec, H2W 1T8, Canada
-
Novartis Investigative Site
Montreal, Quebec, H3T 1E2, Canada
-
Novartis Investigative Site
Montreal, Quebec, H4A 3J1, Canada
-
Novartis Investigative Site
Québec, Quebec, G1R 2J6, Canada
-
Novartis Investigative Site
Sherbrooke, Quebec, J1H 5N4, Canada
-
Novartis Investigative Site
Nanjing, Jiangsu, 210006, China
-
Novartis Investigative Site
Nanjing, Jiangsu, 210029, China
-
Novartis Investigative Site
Xian, Shanxi, 710032, China
-
Novartis Investigative Site
Chengdu, Sichuan, 610041, China
-
Novartis Investigative Site
Beijing, 100036, China
-
Novartis Investigative Site
Guangzhou, 510060, China
-
Novartis Investigative Site
Shanghai, 200025, China
-
Novartis Investigative Site
Shanghai, 200032, China
-
Novartis Investigative Site
Shanghai, 200080, China
-
Novartis Investigative Site
Tianjin, 300308, China
-
Novartis Investigative Site
Olomouc, 779 00, Czechia
-
Novartis Investigative Site
Prague, 150 06, Czechia
-
Novartis Investigative Site
Copenhagen, DK-2100, Denmark
-
Novartis Investigative Site
Bordeaux, 33075, France
-
Novartis Investigative Site
Clermont-Ferrand, 63011, France
-
Novartis Investigative Site
Lyon, 69373, France
-
Novartis Investigative Site
Montpellier, 34298, France
-
Novartis Investigative Site
Nantes, 44093, France
-
Novartis Investigative Site
Paris, 75015, France
-
Novartis Investigative Site
Paris, 75018, France
-
Novartis Investigative Site
Strasbourg, 67000, France
-
Novartis Investigative Site
Vandœuvre-lès-Nancy, 54511, France
-
Novartis Investigative Site
Villejuif, 94800, France
-
Novartis Investigative Site
Würzburg, Bavaria, 97080, Germany
-
Novartis Investigative Site
Cologne, North Rhine-Westphalia, 50937, Germany
-
Novartis Investigative Site
Essen, 45147, Germany
-
Novartis Investigative Site
München, 80377, Germany
-
Novartis Investigative Site
Münster, 48149, Germany
-
Novartis Investigative Site
Rostock, 18057, Germany
-
Novartis Investigative Site
Nagoya, Aichi-ken, 4668560, Japan
-
Novartis Investigative Site
Sapporo, Hokkaido, 0608648, Japan
-
Novartis Investigative Site
Kobe, Hyōgo, 6500047, Japan
-
Novartis Investigative Site
Yokohama, Kanagawa-ku, 236-0004, Japan
-
Novartis Investigative Site
Suita, Osaka, 5650871, Japan
-
Novartis Investigative Site
Kitaadachi-gun, Saitama, 3620806, Japan
-
Novartis Investigative Site
Bunkyo Ku, Tokyo, 1138431, Japan
-
Novartis Investigative Site
Chuo Ku, Tokyo, 1040045, Japan
-
Novartis Investigative Site
Chiba, 260-8717, Japan
-
Novartis Investigative Site
Fukuoka, 811-0213, Japan
-
Novartis Investigative Site
Fukuoka, 812-0033, Japan
-
Novartis Investigative Site
Fukuoka, 8128582, Japan
-
Novartis Investigative Site
Fukushima, 9601295, Japan
-
Novartis Investigative Site
Kumamoto, 860-8556, Japan
-
Novartis Investigative Site
Kyoto, 6068507, Japan
-
Novartis Investigative Site
Okayama, 7008558, Japan
-
Novartis Investigative Site
Yamagata, 990 9585, Japan
-
Novartis Investigative Site
Nijmegen, Gelderland, 6500HB, Netherlands
-
Novartis Investigative Site
Maastricht, Limburg, 6229 HX, Netherlands
-
Novartis Investigative Site
Delft, South Holland, 2625 AD, Netherlands
-
Novartis Investigative Site
Utrecht, 3584 CX, Netherlands
-
Novartis Investigative Site
Gliwice, Silesian Voivodeship, 44-101, Poland
-
Novartis Investigative Site
Krakow, 30-688, Poland
-
Novartis Investigative Site
Warsaw, 02-781, Poland
-
Novartis Investigative Site
Singapore, 119228, Singapore
-
Novartis Investigative Site
Singapore, 168583, Singapore
-
Novartis Investigative Site
Seoul, Korea, 03080, South Korea
-
Novartis Investigative Site
Seoul, 03722, South Korea
-
Novartis Investigative Site
Seoul, 05505, South Korea
-
Novartis Investigative Site
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
-
Novartis Investigative Site
Sabadell, Barcelona, 08208, Spain
-
Novartis Investigative Site
Majadahonda, Madrid, 28222, Spain
-
Novartis Investigative Site
El Palmar, Murcia, 30120, Spain
-
Novartis Investigative Site
Barcelona, 08035, Spain
-
Novartis Investigative Site
Barcelona, 08036, Spain
-
Novartis Investigative Site
Madrid, 28034, Spain
-
Novartis Investigative Site
Madrid, 28040, Spain
-
Novartis Investigative Site
Madrid, 28041, Spain
-
Novartis Investigative Site
Madrid, 28046, Spain
-
Novartis Investigative Site
Valencia, 46026, Spain
-
Novartis Investigative Site
Gothenburg, 413 45, Sweden
-
Novartis Investigative Site
Lund, 221 85, Sweden
-
Novartis Investigative Site
Stockholm, 17176, Sweden
-
Novartis Investigative Site
Bern, 3010, Switzerland
-
Novartis Investigative Site
Lausanne, 1011, Switzerland
-
Novartis Investigative Site
Taipei, 10002, Taiwan
-
Novartis Investigative Site
Taoyuan District, 33305, Taiwan
-
Novartis Investigative Site
Sutton, Surrey, SM2 5PT, United Kingdom
-
Novartis Investigative Site
Belfast, BT9 7AB, United Kingdom
-
Novartis Investigative Site
Cambridge, CB2 0QQ, United Kingdom
-
Novartis Investigative Site
Glasgow, G12 0YN, United Kingdom
-
Novartis Investigative Site
London, EC1A 7BE, United Kingdom
-
Novartis Investigative Site
London, NW1 2BU, United Kingdom
-
Novartis Investigative Site
London, NW3 2QG, United Kingdom
-
Novartis Investigative Site
Middlesbrough, TS4 3BW, United Kingdom
-
Ochsner Clinic Foundation
New Orleans, Louisiana, 70121, United States
-
Onco Hemato Asso of SW Virginia
Roanoke, Virginia, 24014, United States
-
Oregon Health Sciences University
Portland, Oregon, 97239, United States
-
Parkview Research Center
Fort Wayne, Indiana, 46845, United States
-
Penn State Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
Providence Saint Johns Health Ctr
Santa Monica, California, 90404, United States
-
Rocky Mountain Cancer Centers
Denver, Colorado, 80218, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
Sansum Clinic
Santa Barbara, California, 93105, United States
-
Sidney Kimmel CCC At JH
Baltimore, Maryland, 21231, United States
-
St. Joseph Hospital
Orange, California, 92686, United States
-
St. Louis University
St Louis, Missouri, 63104, United States
-
Stanford University Medical Center
Palo Alto, California, 94304, United States
-
Swedish Medical Center
Seattle, Washington, 98122-4379, United States
-
Texas Oncology
Dallas, Texas, 75246, United States
-
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43221, United States
-
The Queens Medical Centre
Honolulu, Hawaii, 96813, United States
-
Thomas Jefferson Univ Hosp
Philadelphia, Pennsylvania, 19107, United States
-
Tulane Cancer Center
New Orleans, Louisiana, 70112, United States
-
UT Health San Antonio Mays Cancer Center
San Antonio, Texas, 78229, United States
-
UT Health Science Center
Houston, Texas, 77030, United States
-
Uni Of Michigan Health System
Ann Arbor, Michigan, 48109, United States
-
Univ Cali Irvine ALS Neuromuscular
Orange, California, 92868, United States
-
Univ Of Color Anschutz Med Center
Aurora, Colorado, 80045, United States
-
Univ Of Rochester Cancer Ctr
Rochester, New York, 14642, United States
-
Univ of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, 15232, United States
-
Univ of Texas Southwest Med Center
Dallas, Texas, 75390-9034, United States
-
University Cancer and Blood Center LLC
Athens, Georgia, 30607, United States
-
University Of Miami
Miami, Florida, 33136, United States
-
University of California LA
Los Angeles, California, 90095, United States
-
University of California San Diego - Moores Cancer Center
La Jolla, California, 92093-0658, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
-
University of Mississippi Med Ctr
Jackson, Mississippi, 39216, United States
-
University of New Mexico
Albuquerque, New Mexico, 87131 0001, United States
-
University of Virginia Medical Center
Charlottesville, Virginia, 22908, United States
-
Urology Cancer Center PC
Omaha, Nebraska, 68130, United States
-
VA Greater LA Healthcare System
Los Angeles, California, 90073, United States
-
VA Medical Center
Washington D.C., District of Columbia, 20422, United States
-
VA Palo Alto Health Care System
Palo Alto, California, 94304-1207, United States
-
VA St Louis Health Care System
St Louis, Missouri, 63106, United States
-
Virginia Oncology Associates
Norfolk, Virginia, 23502, United States
-
Wash U School of Medicine
St Louis, Missouri, 63110, United States
-
Weill Cornell Medical College
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.